Friday, January 24, 2014 IOM Seeking Comment on Clinical Trials Data Sharing In a health care world that places increasing emphasis on outcome data, some of the richest information from clinical trials can be the least accessible because of barriers to sharing. Now the US National Academy of Sciences' Institute of Medicine (IOM) is looking for ways to solve those access problems and asking for feedback on the issue. In a recently released report titled Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities, a specially formed IOM committee outlines its progress on efforts to rethink data restrictions that, if relaxed, "could facilitate new analyses and a deeper understanding of a particular therapy or condition," in the committee's opinion. The report states that "a cultural change" has taken place in current thinking about data sharing, and that "the conversation … has moved from whether it should happen to how it should be carried out." The committee's efforts to identify ways to carry out greater data sharing include gathering input from the providers and researchers. The group is particularly interested in feedback on global implementation, the timing and prioritization of sharing, mitigating risks, enhancing incentives, and measuring impact, and has produced a guideline for providing public comment (.pdf).